BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 1318414)

  • 1. The human cytomegalovirus 80-kilodalton but not the 72-kilodalton immediate-early protein transactivates heterologous promoters in a TATA box-dependent mechanism and interacts directly with TFIID.
    Hagemeier C; Walker S; Caswell R; Kouzarides T; Sinclair J
    J Virol; 1992 Jul; 66(7):4452-6. PubMed ID: 1318414
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A 10-base-pair element of the human immunodeficiency virus type 1 long terminal repeat (LTR) is an absolute requirement for transactivation by the human cytomegalovirus 72-kilodalton IE1 protein but can be compensated for by other LTR regions in transactivation by the 80-kilodalton IE2 protein.
    Walker S; Hagemeier C; Sissons JG; Sinclair JH
    J Virol; 1992 Mar; 66(3):1543-50. PubMed ID: 1310765
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transactivation activity of the human cytomegalovirus IE2 protein occurs at steps subsequent to TATA box-binding protein recruitment.
    Kim JM; Hong Y; Jeang KT; Kim S
    J Gen Virol; 2000 Jan; 81(Pt 1):37-46. PubMed ID: 10640540
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The human cytomegalovirus 86K immediate early (IE) 2 protein requires the basic region of the TATA-box binding protein (TBP) for binding, and interacts with TBP and transcription factor TFIIB via regions of IE2 required for transcriptional regulation.
    Caswell R; Hagemeier C; Chiou CJ; Hayward G; Kouzarides T; Sinclair J
    J Gen Virol; 1993 Dec; 74 ( Pt 12)():2691-8. PubMed ID: 8277274
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human cytomegalovirus immediate-early gene 2 protein interacts with itself and with several novel cellular proteins.
    Furnari BA; Poma E; Kowalik TF; Huong SM; Huang ES
    J Virol; 1993 Aug; 67(8):4981-91. PubMed ID: 8392623
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transactivation by the human cytomegalovirus IE2 86-kilodalton protein requires a domain that binds to both the TATA box-binding protein and the retinoblastoma protein.
    Sommer MH; Scully AL; Spector DH
    J Virol; 1994 Oct; 68(10):6223-31. PubMed ID: 8083962
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of binding sites for the 86-kilodalton IE2 protein of human cytomegalovirus within an IE2-responsive viral early promoter.
    Arlt H; Lang D; Gebert S; Stamminger T
    J Virol; 1994 Jul; 68(7):4117-25. PubMed ID: 8207790
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TAR and Sp1-independent transactivation of HIV long terminal repeat by the Tat protein in the presence of human cytomegalovirus IE1/IE2.
    Dal Monte P; Landini MP; Sinclair J; Virelizier JL; Michelson S
    AIDS; 1997 Mar; 11(3):297-303. PubMed ID: 9147420
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of human cytomegalovirus target sequences in the human immunodeficiency virus long terminal repeat. Potential role of IE2-86 binding to sequences between -120 and -20 in promoter transactivation.
    Yurochko AD; Huong SM; Huang ES
    J Hum Virol; 1999; 2(2):81-90. PubMed ID: 10225210
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The 72K IE1 and 80K IE2 proteins of human cytomegalovirus independently trans-activate the c-fos, c-myc and hsp70 promoters via basal promoter elements.
    Hagemeier C; Walker SM; Sissons PJ; Sinclair JH
    J Gen Virol; 1992 Sep; 73 ( Pt 9)():2385-93. PubMed ID: 1328493
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Competition with TATA box-binding protein for binding to the TATA box implicated in human cytomegalovirus IE2-mediated transcriptional repression of cellular promoters.
    Wang YC; Huang CF; Tung SF; Lin YS
    DNA Cell Biol; 2000 Oct; 19(10):613-9. PubMed ID: 11058964
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TAF-like functions of human cytomegalovirus immediate-early proteins.
    Lukac DM; Harel NY; Tanese N; Alwine JC
    J Virol; 1997 Oct; 71(10):7227-39. PubMed ID: 9311796
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human cytomegalovirus US3 and UL36-38 immediate-early proteins regulate gene expression.
    Colberg-Poley AM; Santomenna LD; Harlow PP; Benfield PA; Tenney DJ
    J Virol; 1992 Jan; 66(1):95-105. PubMed ID: 1370097
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human cytomegalovirus immediate-early 2 (IE2) protein can transactivate the human hsp70 promoter by alleviation of Dr1-mediated repression.
    Caswell R; Bryant L; Sinclair J
    J Virol; 1996 Jun; 70(6):4028-37. PubMed ID: 8648740
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IE2 protein is insufficient for transcriptional repression of the human cytomegalovirus US3 promoter.
    Biegalke BJ
    J Virol; 1997 Oct; 71(10):8056-60. PubMed ID: 9311904
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transactivation of the cytomegalovirus ICP36 gene promoter requires the alpha gene product TRS1 in addition to IE1 and IE2.
    Stasiak PC; Mocarski ES
    J Virol; 1992 Feb; 66(2):1050-8. PubMed ID: 1370547
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Negative regulation of a heterologous promoter by human cytomegalovirus immediate-early protein IE2.
    Tsai HL; Kou GH; Tang FM; Wu CW; Lin YS
    Virology; 1997 Nov; 238(2):372-9. PubMed ID: 9400610
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutations of the human cytomegalovirus immediate-early 2 protein defines regions and amino acid motifs important in transactivation of transcription from the HIV-1 LTR promoter.
    Yeung KC; Stoltzfus CM; Stinski MF
    Virology; 1993 Aug; 195(2):786-92. PubMed ID: 8337845
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transactivation of a human cytomegalovirus early promoter by gene products from the immediate-early gene IE2 and augmentation by IE1: mutational analysis of the viral proteins.
    Malone CL; Vesole DH; Stinski MF
    J Virol; 1990 Apr; 64(4):1498-506. PubMed ID: 2157038
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human cytomegalovirus product UL44 downregulates the transactivation of HIV-1 long terminal repeat.
    Boccuni MC; Campanini F; Battista MC; Bergamini G; Dal Monte P; Ripalti A; Landini MP
    AIDS; 1998 Mar; 12(4):365-72. PubMed ID: 9520165
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.